(HealthDay)—For patients with early breast cancer, five years of zoledronate treatment after chemotherapy does not improve prognosis versus two years of treatment, according to a study published online June 24 in JAMA Oncology.
Jun 25, 2021
0
2
(HealthDay)—Electroacupuncture and auricular acupuncture are more effective than usual care at reducing chronic musculoskeletal pain in cancer survivors, according to a study published online March 18 in JAMA Oncology.
Apr 6, 2021
0
7
For patients with psoriatic arthritis, upadacitinib at a dose of 15 mg or 30 mg once daily is more effective than placebo, according to a study published in the April 1 issue of the New England Journal of Medicine.
Apr 1, 2021
0
3
(HealthDay)—A structured surveillance program for high-risk melanoma patients can be scaled and successfully replicated even in a primary care skin cancer clinic, according to a study published online March 17 in JAMA Dermatology.
Mar 23, 2021
0
2
(HealthDay)—For patients with in-hospital acute kidney injury (AKI), those with COVID-19-associated AKI have a greater rate of decrease in the estimated glomerular filtration rate (eGFR) after discharge, according to a ...
Mar 11, 2021
0
4
(HealthDay)—Tirbanibulin is superior to vehicle at two months for the treatment of actinic keratosis, but almost half of patients who had a complete response experienced recurrence of lesions at one year, according to a ...
Feb 11, 2021
0
1
(HealthDay)—For moderate-to-severe plaque psoriasis, bimekizumab is more efficacious than ustekinumab and placebo, according to a study published in the Feb. 6 issue of The Lancet.
Feb 5, 2021
0
2
(HealthDay)—Taken every other day, rimegepant demonstrates efficacy for the preventive treatment of migraine, according to a study published online Dec. 15 in The Lancet.
Dec 21, 2020
0
6
(HealthDay)—U.S. nephrology trainees report moderate and low confidence for peritoneal dialysis (PD) and home hemodialysis (HHD), respectively, according to a study published online Nov. 16 in the American Journal of Kidney ...
Nov 23, 2020
0
1
(HealthDay)—Vosoritide increases bone growth velocity in children with achondroplasia, the most common form of dwarfism, according to a study recently published in The Lancet.
Oct 27, 2020
0
2
